سعر اديمكس 0.5 مجم/2 مل 3 امبولات 0.25 مجم/مل 2026

Bumetanide 0.5 mg/2 ml injection for IM/IV use (Memphis, Egypt).

• Loop diuretic for edema associated with congestive heart failure, hepatic disease, and renal disease including the nephrotic syndrome (US injectable bumetanide labeling; Memphis page describes diuretic action).Population: AdultsDailyMed (NLM)

• Anuria; hepatic coma; known hypersensitivity to bumetanide or sulfonamides (class considerations per loop-diuretic labeling).General active-ingredient information · DailyMed (NLM)

• Profound diuresis with water/electrolyte depletion can occur; monitor fluid and electrolytes. Ototoxicity risk increases with high IV doses or concomitant ototoxic drugs.General active-ingredient information · DailyMed (NLM)

• Loop diuretics can lead to fetal volume depletion; use in pregnancy only if potential benefit justifies potential risk (ingredient-level).General active-ingredient information · DailyMed (NLM)

• Bumetanide: Inhibits Na-K-2Cl cotransport in the thick ascending limb of the loop of Henle; ~1 mg oral roughly equipotent to 40 mg furosemide.